Sheri Rhodes, serving as a director at FormFactor Inc. (NASDAQ: FORM), has executed a notable equity transaction, disposing of 6,328 shares of the company's common stock on June 2, 2026. The divestment was executed at a price point of $125.40 per share, resulting in a total transaction value of approximately $793,531. The execution price of the sale aligns closely with the stock's prevailing market price of $126.67, reflecting a robust upward trajectory that has seen the equity surge by 293% over the trailing twelve-month period.
Following the completion of this transaction, Ms. Rhodes maintains a direct holding of 5,375 shares of FormFactor common stock. Data sourced from InvestingPro indicates that the equity currently appears overvalued at its present trading levels. Investors seeking further insights may access 19 additional ProTips alongside comprehensive analysis through InvestingPro’s detailed research reports.
The insider transaction occurs amidst a period of strong financial performance for FormFactor. The company recently reported financial results for the first quarter of 2026 that surpassed both earnings and revenue expectations. FormFactor achieved an earnings per share (EPS) of $0.56, a figure that significantly exceeded the forecasted consensus of $0.44. Furthermore, the company generated revenue of $226.1 million, representing a 10.94% increase over the anticipated figure of $203.84 million.
The robust quarterly performance has prompted several analyst firms to adjust their outlooks on FormFactor. Craig-Hallum upgraded the stock from a Hold rating to a Buy rating, establishing a price target of $175 based on the company’s potential earnings power. Northland also raised its price target to $118, citing the strong quarterly performance and guidance that exceeded consensus expectations. Additionally, Stifel increased its price target to $135, noting the company’s strong margins and non-GAAP earnings per share that surpassed expectations.
A key driver behind the positive analyst reviews was the improvement in FormFactor’s gross margins, which expanded by 510 basis points quarter-over-quarter to reach 49.0%. This margin expansion contributed significantly to the favorable reassessments of the company's financial health and market position.
Key Points
- Director Equity Transaction: Director Sheri Rhodes sold 6,328 shares at $125.40, totaling ~$793,531, leaving her with 5,375 direct shares.
- Strong Q1 2026 Financials: FormFactor reported EPS of $0.56 vs. $0.44 expected, and revenue of $226.1M vs. $203.84M expected, driving analyst upgrades.
- Analyst Upgrades: Craig-Hallum, Northland, and Stifel raised price targets and outlooks following the earnings beat and margin expansion.
Market Sectors Impacted
- Technology and Semiconductor Equipment
- Financial Services and Equity Research
Risks and Uncertainties
- Valuation Concerns: Data from InvestingPro suggests the stock appears overvalued at current levels, indicating potential downside risk if growth does not sustain.
- Market Volatility: The stock's 293% surge over the past year may expose it to heightened volatility and correction pressures.
Tags: FORM, Insider Trading, Semiconductor, Earnings, Analyst Upgrades